There is currently no cure for pulmonary fibrosis and patients often face a prognosis of three to five years after diagnosis. However, medication and other treatment options can help improve patients’ quality of life. But as the disease evolves, there are some complications that…
The Canadian Pulmonary Fibrosis Foundation shared this video in 2015, where they show you some exercises that can help pulmonary fibrosis patients to improve their health and gain more muscle and respiratory strength. Watch the video to learn more about how you can…
Johns Hopkins School of Medicine researchers demonstrated that the smallpox vaccine may reverse established lung fibrosis in mice. The vaccine changed the reactivity of various types of immune T-cells, suggesting that balancing the actions of these immune players could be crucial in developing immunotherapeutic treatments for lung fibrosis. Scientists have known for some…
Clinical trials are needed for medical treatments to be approved by government organizations, such as the US Food and Drug Administration (FDA). Without clinical trials, doctors and other prescribing healthcare providers (such as nurse practitioners or physician’s assistants) cannot prescribe medications or recommend other medical treatments. If…
In this video from the Wall Street Journal, watch Wall Street Journal Reporter Tanya Rivero from “Lunch Break With Tanya Rivero”, interview Laura Landro, WSJ Asst. Managing Editor. In this video, they talk about how idiopathic pulmonary fibrosis, a rare lung disease, is…
Clinical trials are well-designed studies that collect information about new treatments for diseases and disorders. Most of the time, this means medications, but clinical trials can also test other things, such as stem cell therapies, surgical techniques, tests for diagnosis, medical devices, and more. There…
Researchers at the Medical University of South Carolina found that M10, a naturally occurring small peptide, appeared to effectively reduce lung fibrosis in a mouse model of systemic sclerosis, a finding that might lead the way to new treatments for lung fibrosis. Systemic sclerosis can be viewed as the archetypal fibrotic disease,…
Pulmonary fibrosis is a really difficult disease to diagnose. To ensure you get an accurate diagnosis and to determine the type of PF you have, doctors from a variety of specialties, including pulmonologists (respirologists), radiologists, rheumatologists, and pathologists have to work together. To learn more about…
https://www.youtube.com/watch?v=azsl8oa76Vs Boehringer Ingelheim shared this video where they show you how hard it is to live with IPF. Pulmonary fibrosis patients feel like they have to put their lives on hold, all the time. Making pit stops to get their breath again and not…
Galapagos NV recently announced the launch of an exploratory Phase 2a clinical trial, called FLORA, evaluating the company’s proprietary drug GLPG1690 in patients with idiopathic pulmonary fibrosis (IPF). Esbriet (pirfenidone) and Ofev (nintedanib) are the only approved therapies for the treatment of IPF, and both have been shown…
Get regular updates to your inbox.
